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Background: Few trials have evaluated the effectiveness of psychological treatment in improving depression by
the end of pregnancy. This is the first pilot randomised controlled trial (RCT) of individual cognitive behavioural
therapy (CBT) looking at treating depression by the end of pregnancy. Our aim was to assess the feasibility of
delivering a CBT intervention modified for antenatal depression during pregnancy.
Methods: Women in North Bristol, UK between 8–18 weeks pregnant were recruited through routine contact with
midwives and randomised to receive up to 12 sessions of individual CBT in addition to usual care or to continue
with usual care only. Women were eligible for randomisation if they screened positive on a 3-question depression
screen used routinely by midwives and met ICD-10 criteria for depression assessed using the clinical interview
schedule – revised version (CIS-R). Two CBT therapists delivered the intervention. Follow-up was at 15 and 33 weeks
post-randomisation when assessments of mental health were made using measures which included the CIS-R.
Results: Of the 50 women assessed for the trial, 36 met ICD-10 depression criteria and were randomised: 18 to the
intervention and 18 to usual care. Thirteen of the 18 (72%) women who were allocated to receive the intervention
completed 9 or more sessions of CBT before the end of pregnancy. Follow-up rates at 15 and 33 weeks post-
randomisation were higher in the group who received the intervention (89% vs. 72% at 15 weeks and 89% vs. 61%
at 33 weeks post-randomisation). At 15 weeks post-randomisation (the end of pregnancy), there were more women
in the intervention group (11/16; 68.7%) who recovered (i.e. no longer met ICD-10 criteria for depression), than
those receiving only usual care (5/13; 38.5%).
Conclusions: This pilot trial shows the feasibility of conducting a large RCT to assess the effectiveness of CBT for
treating antenatal depression before the end of pregnancy. The intervention could be delivered during the
antenatal period and there was some evidence to suggest that it could be effective.
Trial registration: ISRCTN44902048
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Depression is common in women of childbearing age.
One large systematic review found a period prevalence for
major depression of 12.7% across the 9 months of preg-
nancy and 7.1% in the first three months postnatally [1].
There has been considerably more research on postnatal
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reproduction in any medium, provided the ordepression but the latter can also have adverse effects on
both mother and baby. Women who experience perinatal
depression are more likely to have a poor couple relation-
ship, to self-harm [2-4], and it can affect the developing
child independently of the occurrence of postnatal depres-
sion [5-8]. Antenatal depression has an impact on neo-
natal development through several mechanisms. Women
who are depressed during pregnancy are more likely to
smoke cigarettes, use alcohol and other illicit substances
[9,10], to experience preeclampsia and other obstetric
complications [11,12]. The consequences of these to theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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delivery, and reduced motor activity [13-17].
Many of those depressed in pregnancy do not recover
and depression continues postnatally. One study found
that 50% of women with high depression scores at 2 -
months postnatally had high depression scores at 32 weeks
antenatally [6]. Some of the consequences attributed to
postnatal depression could therefore be due to antenatal
depression. Identification and treatment of depression at
this time has therefore become a health service priority
and has been recommended in National treatment
guidelines in the UK (NICE ) [18].
There have been a number of studies which have
shown psychological and psychosocial treatments to be
effective in improving mood postnatally [19-21]. In con-
trast, there have been few studies on the treatment of
antenatal depression that aim to improve depression be-
fore the end of pregnancy and only one small trial using
interpersonal therapy [22]. Although there are a number
of other studies that begin during pregnancy [23,24]
their primary aim is to prevent postnatal depression and
other adverse postnatal outcomes rather than to success-
fully treat depression before the end of pregnancy.
The antenatal period provides a unique opportunity to
identify and treat depression, as there is contact with
general practitioners (GPs) and midwives from the first
trimester, and there may be fewer practical barriers to
treatment at this time, compared to postnatal depression
when the mother has a young infant to care for. If the
consequences for child development are to be prevented,
then treatment needs to be prompt in order to improve
mood before the end of pregnancy.
The choice of intervention in pregnancy is complicated
by the need to consider the foetus as well as the mother.
Guidance in the UK for treating antenatal depression
recommends cognitive behavioural therapy (CBT) or
interpersonal therapy (IPT) for severe or moderate depres-
sion in those with a previous history. Although the efficacy
of CBT in the treatment of depression has been
established outside the antenatal period, the effectiveness
and feasibility of this approach and implementing it within
the healthcare system during pregnancy is unknown.
There are several reasons why this extrapolation to
pregnancy, of treatments that are effective at other
times, is inadequate. First, the risk benefit ratio for
antidepressant treatment differs at this time [25,26]. There
are known adverse consequences for the developing foetus
of some antidepressants [27,28], an association with a
lower gestational age at birth and an increased risk of pre-
term birth [29] and the acceptability of pharmacological
treatment during pregnancy is lower [26]. Therefore the
consequence of this is that fewer women are using
antidepressants during pregnancy than any other time
therefore CBT is more likely to be delivered in the absenceof antidepressants whilst the efficacy of this is known the
effectiveness in this context is unknown. Second, the con-
text in which the treatment is offered is different. There is
an assumption that standard CBT approaches will work
but some adaptations in content and delivery are needed.
There are unique demands to a pregnant woman’s time,
attention and energy, which may have an impact on the
delivery of CBT. There are particular concerns during this
period such as pregnancy specific worries and rumination
is heightened along with interpersonal and social support
needs [30]. Finally, there is a more urgent need to provide
a timely intervention as a delay, could compromise any
benefits there may be on foetal development.
With this in mind we conducted a pilot RCT to assess
the feasibility for a large-scale RCT of individual CBT in
the treatment of depression by the end of pregnancy by
piloting procedures for recruitment, assessment and ran-
domisation to treatment, and the delivery of up to 12
sessions of CBT before the end of pregnancy. Data col-
lection procedures were also piloted and included an as-
sessment of the most appropriate way of collecting
health care resource use for this population.
Method
Setting
All Midwives in North Bristol, UK, a mainly urban set-
ting with some areas of high deprivation, were
approached and invited to refer women to the trial. Eth-
ical approval for the trial was given by Southmead Na-
tional Health Service Research Ethics Committee (09/
H0102/75).
Inclusion/exclusion criteria
Eligible participants were women over 16 years of age who
were between 8 and 18 weeks pregnant and who screened
positive on a 3-question depression screen [31]. This is
routinely used by the midwives as recommended in Na-
tional guidance, where a positive depression screen is
answering yes to either or both of the symptoms questions
and yes to wanting help. Women were excluded if they
were currently receiving CBT or any individual or group
psychological therapy for depression or if they had a
psychotic illness. Women who did not have sufficient
command of English to complete the questionnaires or
benefit from an individual talking therapy without an in-
terpreter were also excluded due to the small scale of the
pilot trial.
Recruitment
Women were recruited at their midwife ‘booking ap-
pointment’. These appointments are arranged early in
pregnancy and in North Bristol 85% of women have had
their booking appointment by 14 weeks of pregnancy.
We wanted to establish early contact in order to avoid a
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women were able to complete therapy during pregnancy.
At their booking appointment, women were asked to
complete a form giving permission to be contacted by
the research team. For those consenting to be contacted,
and if the midwife indicated on the 3-question screen
that the women may be suffering from depression and
would like help, she was given a more detailed information
sheet about the trial and a leaflet on CBT. The completed
permission to contact forms were returned to the research
team by post or fax, the women were contacted, the study
formally introduced, eligibility checks conducted and
an appointment arranged for a baseline assessment. At
this appointment, at the woman’s home, the study was
explained in more detail, the computerised version of the
Clinical Interview Schedule – revised (CIS-R) [32] was
completed to confirm eligibility. Those who met ICD-10
criteria on the CIS-R for depression (mild, moderate or se-
vere) were asked to give written informed consent to be
randomised.
Randomisation
Eligible women were randomised to one of two groups:
(1) CBT in addition to usual care; or (2) to continue
with usual care only. Allocation was concealed through
the use of a central randomisation service that was
accessed via the internet and used a computer generated
code. Minimisation was used to ensure balance between
the trial groups on 4 key design variables: age (< or ≥
18) depression severity (mild, moderate or severe),
current symptom duration (< or ≥ 3 months) and history
of depression (yes or no). Women were informed of the
outcome of randomisation at the end of the assessment
by the researcher. The woman’s GP and midwife were
informed that they had depression, had agreed to take
part in the study and the group to which they were
randomised.
Intervention
The intervention consisted of up to 12 individual sessions
of CBT at the woman’s home unless a preference was
expressed to be seen elsewhere. Two therapists, one with
master’s level experience and the other with doctoral ex-
perience in CBT, were trained to deliver the intervention
until judged to be competent. Training the therapist to
competence consisted of following an intervention manual
modified in previous research to fit with the content needs
of perinatal depression [33], reviewing and training in
key perinatal adaptations, and role plays with the trial
Clinical Supervisor (HO), a Clinical Psychologist with
specialist perinatal expertise. Modification of the CBT
included paying attention to the role of maternal beliefs,
the unique environmental constraints surrounding behav-
ioural activation (e.g., small chunks of available time,balancing multiple valued goals and time-sensitive pressures),
and incorporating principles and strategies that address the
ways to improve communication and social support. Therap-
ist competence was assessed with the Revised Cognitive
Therapy Scale [CTS-R) [34]. In addition, 10% of cases
were randomly selected each week to be audiotaped for
monitoring adherence to treatment by the clinical supervisor.
Issues of non-adherence to the treatment model (e.g. being
directive, incorporating strategies from other treatments)
were addressed in weekly clinical supervision. Therapists
were advised on how to refocus treatment within the trial
intervention framework.
An adequate ‘dose’ of CBT for the trial was defined be-
forehand as at least 9 sessions. This definition was based
on the findings of a meta-analysis of CBT in preventing
depression that found the strongest effect size in clinical
trials offering more than 8 sessions [35]. Although there
is some evidence that 12 sessions is the minimum length
for which there is evidence of clinical efficacy of CBT in
moderate and severe depression [36,37], this must be
considered alongside the practical constraints involved
in conducting therapy in the antenatal period [38].
Usual care
After booking, women in both trial groups continued
to receive usual care from their midwife and GP. For a
first time mother this usually included a further 9
appointments with midwives after the booking plus scans
(a dating and anomaly scan) or 6 further appointments
and scans if they have had previously had a baby. Mid-
wives routinely decide how frequently to meet pregnant
women depending on their perceived needs and available
resources. Information on this care was collected from
medical and maternity records.
Data collection and outcome measures
Women were assessed at baseline, at 15 weeks and 33 -
weeks post-randomisation. The primary outcome for
the full scale trial, that was piloted here, was recovery
i.e. not depressed according to ICD-10 at 15 weeks
post-randomisation. The CIS-R is a self-administered
computerised interview and gives an ICD-10 diagnosis of
mild, moderate or severe depression as well as a total
symptom score based on the duration and severity of de-
pression and neurotic symptoms. A total symptom score
above a threshold of 12 indicates the individual has a diag-
nosable mental health disorder, including anxiety [32,39].
The reliability and validity of the CIS-R are comparable
with the composite interview national diagnostic interview
[40]. The CIS-R was slightly adapted so that participants
answering questions relating to symptoms of pregnancy,
such as sleep, fatigue and appetite, were asked to distin-
guish whether their experiences were due to pregnancy or
their mood.
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33 weeks post-randomisation) for a full scale trial,
piloted here, included the Patient Health Question-
naire (PHQ-9, not modified for pregnancy) and Edin-
burgh Postnatal Depression Scale (EPDS) [41,42]
which were both computer administered. Both these
measures are commonly used self-report depression
measures suggested by NICE guidance to be used as
part of the assessment following the 3-question screen.
The Short form questionnaire-12 items (SF-12), was
used as a measure of quality of life [43], the EQ-5D as
a measure of health outcome [44] and the Prenatal At-
tachment Inventory was used to assess the level, qual-
ity and intensity of the bond between a women and
her foetus (scores range from 21 to 84 with higher
scores indicating increased attachment quality/inten-
sity) [45]. The Metacognitive Awareness Questionnaire
was used to measure how aware participants were of
the differences in their thinking according to their
mood, where higher scores reflect greater meta-cognitive
awareness [46]. The number of midwife appointments and
GP visits were recorded via patient-reported resource-
use questionnaires (RUQs) developed for this study.
Midwife appointments and GP visits were identified
from medical records, and additional midwife data
from maternity notes.
Statistical analyses
The characteristics of those women who were randomised
were described using appropriate descriptive statistics.
The proportion of women; recruited to the trial, complet-
ing therapy and followed up were calculated, as well as the
proportion recovering from depression in each group. Lo-
gistic regression was used to compare the difference in the
proportion who ‘recovered’ between the two groups as
randomised (‘intention-to-treat’ basis), adjusting for the
four minimisation variables: age (< or ≥ 18); depression se-
verity (mild, moderate or severe); current symptom dur-
ation (< or ≥ 3 months); and history of depression (yes
or no). A sensitivity analysis was conducted to examine
the impact of missing data on findings using a best /worst
case scenario (i.e. assuming that all those who were
missing ‘recovered’ or ‘did not recover’). Differences be-
tween groups on the continuous CIS-R score were
compared using linear regression. Similar regression mo-
dels were used for secondary outcomes. Odds ratios (OR),
or differences in means, 95% confidence intervals (95%
CI) and p values are reported.
For the health economic analysis, mean monthly
contacts were derived for the number of midwife and
GP appointments recorded by the different methods;
Wilcoxon signed-ranks tests were used to compare the
methods. All statistical analysis was performed using
STATA version 12.1.Results
Recruitment
According to computerised records from NHS Bristol,
during the recruitment period of the study between May
2010 and February 2011, there were approximately 5,409
women who attended booking clinics, of those 154 women
screened positive on the 3-question screen for depression
and were therefore potentially eligible for assessment for
the trial. Figure 1 presents a CONSORT diagram of the
flow of women through the trial. The data from NHS Bris-
tol was information on bookings between August 2010
and July 20011 so the figures above are approximations.
In total we received replies from 101 women who gave
permission to be contacted (65.6%), of those 15 (14.8%)
refused to take part at their booking appointment (main
reasons were; too busy and not wanting to take part in
research). Of the remaining 86 (85.1%) women who
returned a permission to contact form and were poten-
tially eligible, a further 36 (42%) were excluded (main
reasons were; declined after researcher contact, over 18 -
weeks gestation, and miscarriage). A total of 50 women
were assessed for the trial, 13 women did not meet the
entry criteria as they did not have an ICD-10 diagnosis
of depression, one woman did not want therapy (and
declined randomisation), leaving 36 women who were
randomised into the trial. The average time between
booking appointments and randomisation was 21 days
(range= 4–59 days, SD= 13).
The midwives invited only 65.6% (101/154) of women
who were potentially eligible for assessment for the trial.
Reasons given by midwives as to why they failed to refer
were ‘misperceptions about the remit of CBT’, ‘woman too
unwell for CBT’, some midwives thought ‘CBT suited to
those with phobias rather than depression’, some preferred
to offer extra appointments with themselves, or some mid-
wives assuming on the basis of the rest of the booking ap-
pointment that things were going well for the woman and
they did not need to be asked the 3-question screen directly.
Therapy attendance
Eighteen women were randomised to receive the inter-
vention and 18 to receive usual care. Thirteen of the 18
women receiving therapy completed 9 or more sessions
(defined pre-trial as an adequate ‘dose’), giving a comple-
tion rate of 72% (CI 49–87.5). The majority of those
women (n= 10; 76.9%) attended all 12 sessions. Of the
13 women who continued with therapy, only one woman
did not formally complete therapy before giving birth,
however she had received 9 sessions whilst still preg-
nant. The mean gestation when therapy was completed
was 32 weeks (range= 22–40 weeks, SD= 4.5).
A number of sessions were cancelled, with many
women cancelling with less than 24 hours notice, and
the therapist reported a few appointments when the
Assessed for eligibility (n= 50) 
Excluded (n= 14)
Not meeting inclusion criteria (n= 13)
Declined to be randomised (n= 1)
Completed assessment (n= 16)
Completed assessment (n= 16)
Lost to follow-up (n= 2) 
Allocated to intervention (n= 18) 
Completed assessment (n= 13)
Lost to follow-up (n= 2) 
Withdrawn (n= 2)
Miscarried (n=1)
Allocated to usual care (n= 18)
Completed assessment (n= 11)
Lost to follow-up (n= 2)
Baseline
33 weeks post-
randomisation
15 weeks post-
randomisation
Randomised (n= 36) 
Enrollment following 
consent to contact at 
midwife booking
Excluded  (n=36)
Unable to contact (n= 2)
Declined after phone contact (n=10)
Declined before/during baseline/ 
or not at home (n= 6)
Miscarried before assessment (n= 7)
Other Ineligible (e.g over 18wks) (n= 11)
Consent to contact (n= 86)
Declined consent to contact at booking (n= 15)
Invited to take part (n= 101)
Not Invited to take part approx (n= 53) 
Women positive on 3-question screen
(approx number from NHS Bristol computer records)
n= 154
Figure 1 Flow of participant into and through the trial.
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Four women (22.2%) withdrew from therapy before
completion. There were various reasons for their with-
drawal, e.g. unable to fit in around work, too busy,
disliked CBT, or out of the country.
Baseline characteristics
The two groups were similar although, not unsurpris-
ingly given the small numbers, some imbalances were
apparent in ethnicity, marital status, home ownership,
and ever having used antidepressants (Table 1).
Follow-up
Overall, 81% (29/36) of women were followed-up at 15 -
weeks post-randomisation and 75% (27/36) were followedup at 33 weeks post-randomisation (See Figure 1). There
was some evidence of differential attrition, such as those
in the intervention group were more likely to be followed-
up. Follow-up rates were higher in the intervention group
at both 15 weeks and 33 weeks post-randomisation
(See Figure 1).
Outcome at 15 weeks – proposed primary
The proportion of women fulfilling ICD-10 criteria
for depression in each group, at 15 weeks post-
randomisation, is reported in Table 2. The majority,
68.7% in the intervention group no longer met ICD-10
criteria for depression on the CIS-R (‘recovered’)
compared to 38.5% of those receiving usual care. Women
who received the intervention had a 3.6 fold increased
Table 1 Baseline comparability of the randomised groups
BASELINE VALUES Intervention Usual care
n n
Age: mean (SD, range) 18 28.2 yrs (5.0: r= 20–36) 18 30.1 yrs (6.2: r= 21–41)
No. of weeks pregnant at assessment: mean (SD, range) 13 .1 wks (3.2: r= 9–18) 12.7 wks (2.2: r= 10–17)
Ethnicity White 13 72.2% 17 94.4%
No Religion 11 61.1% 12 66.7%
Living with Partner 12 66.7% 10 55.6%
Married/ living as married 13 72.2% 10 55.6%
Socio-economic indicators
Housing tenure (owner) 2 11.1% 8 44.4%
Working (full or part time) 12 66.7% 9 50.0%
Educational Qualification (‘ O’ level or equivalent and above) 15 83.3% 16 88.9%
Financial situation: Just getting by/ difficult 12 66.7% 14 77.8%
Car ownership (none) 10 55.5% 12 66.7%
No. of life event in past 6 months: median [IQR) 18 1.5 [0, 3] 17 1 [0, 4]
Depression History
Reported depression in the past 15 83.3% 16 88.9%
Current duration of depression (more than 3 months) 13 72.2% 13 72.2%
Ever used antidepressants before 10 55.6% 15 83.3%
Currently on antidepressants 2 20.0% 5 33.3%
Clinical variables
ICD-10 Diagnosis - Mild 3 16.7% 3 16.7%
Moderate 10 55.5% 10 55.5%
Severe 5 27.8% 5 27.8%
CIS-R Score: median (SD) 18 26.5 (7.9) 18 30.5 (7.5)
EPDS: median (SD) 18 16.5 (4.3) 18 20 (5.1)
PHQ-9: median (SD) 18 16.0 (4.6) 18 16.0 (5.0)
SF-12 Physical component: mean (SD) 18 43.7 (6.6) 17 45.3 (6.8)
SF-12 Mental component: mean (SD) 18 39.9 (7.6) 17 37.5 (8.2)
EQ-5D: mean (SD) 18 0.6 (0.3) 18 0.6 (0.2)
Metacognitive Awareness Questionnaire: mean (SD) 17 33.3 (7.1) 18 36.2 (6.6)
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with those who continued with usual care (Table 3), al-
though, not unexpectedly given the small sample size, the
95% CI surrounding this estimate was wide and included
the null.Table 2 Primary Diagnosis on the CIS-R at baseline and follow
Baseline 1
Intervention (n= 18) UC (n= 18) Inte
No depression - -
Mild depressive episode 3 (16.7%) 3 (16.7%)
Moderate depressive episode 10 (55.5%) 10 (55.5%)
Severe depressive episode 5 (27.8%) 5 (27.8%)Sensitivity analyses to examine the impact of missing data
were conducted (Table 3). The odds ratio for recovery varied
depending on the assumption made with respect to missing
data, but the results were consistent with those of the pri-
mary analysis, when confidence intervals were compared.-up assessments
5 weeks post-randomisation 33 weeks post-randomisation
(in the postnatal period)
rvention (n= 16) UC (n= 13) Intervention (n= 16) UC (n= 11)
11 (68.7%) 5 (38.4%) 13 (81.2%) 4 (36.4%)
1 (6.3%) 1 (7.7%) 1 (6.3%) -
4 (25%) 5 (38.4%) 2 (12.5%) 5 (45.4%)
- 2 (15.3%) - 2 (18.2%)
Table 3 Percentage and odds ratio of recovery at 15 weeks post-randomisation
N % Odds ratio (1) (95% CI) p-value Odds ratio (2) (95% CI) p-value Odds ratio (3) (95% CI) p-value
Intervention 11 68.7 3.6 (0.5 to 23.2) 0.2 1.5 (0.3 to 8.0) 0.6 3.9 (0.8 to 17.8) 0.1
Usual care 5 38.4
Total N 29 29 36 36
(1) adjusted for CIS-R score at baseline, age (< or ≥ 18) depression severity (mild, moderate or severe), current symptom duration (< or ≥ 3 months) and history of
depression (yes or no).
(2) adujsting for CIS-R score at baseline, allocation group, age (< or ≥ 18) depression severity (mild, moderate or severe), current symptom duration (< or ≥
3 months) and history of depression (yes or no) – assuming all missing ‘recovered’.
(3) adujsting for CIS-R score at baseline, allocation group, age (< or ≥ 18) depression severity (mild, moderate or severe), current symptom duration (< or ≥
3 months) and history of depression (yes or no) - assuming all missing ‘did not recover’.
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As seen in Table 4, continuous CIS-R mean scores were
lower for the intervention group compared with the usual
care group at 15 weeks post-randomisation. After adjust-
ment for baseline CIS-R score and the 4 key design
variables (age, depression severity, current symptom dur-
ation and history of depression), the intervention group
had a mean CIS-R score that was 10 points lower than
those in the usual care group at 15 weeks (Table 4).
Continuous CIS-R outcome at 33 weeks – proposed
secondary
Similar results were seen at 33 weeks post-randomisation.
The majority, 81.2% of the women did not have depression
in the intervention group compared to 36.4% in usual care
only arm (Table 2). The continuous CIS-R mean score
was also lower for the intervention group compared with
the usual care group at 33 weeks post-randomisation.Table 4 Secondary outcome measures: comparing means bet
33 weeks post-randomisation
15 weeks post-randomisation
Intervention UC Adjusted differen
means(1) (95%
p valuen Mean
(sd)
n Mean
(sd)
CIS-R Scores 16 12.4 (9.2) 13 22.3 (11.1) −10.0 (−16.9 to −2
0.007
EPDS 16 7.9 (4.7) 13 13.8 (7.5) −5.9 (−10.3 to −1.5)
PHQ-9 16 6.2 (4.2) 13 11.8 (7.8) −5.6 (−9.9 to −1.3) p
Physical component
of SF12 score*
16 34.5 (7.8) 13 38.5 (5.8) −4.4 (−9.5 to 0.7) p
Mental component
of SF12 score*
16 52.1 (6.4) 13 42.9 (8.9) 10.2 (4.4 to 16.0) p=
Metacognitive
awareness
questionnaire**
16 44.7 (6.2) 12 41.5 (8.1) 5.1 (−0.3 to 10.5) p
EQ-5D* 16 0.78 (0.16) 13 0.72 (0.17) 0.06 (−0.05 to 0.18)
Prenatal Attachment
Inventory
16 60.4 (3.0) 10 47.2 (3.3) 2.6 (2.69 to 22.38) p
(1) adjusted for CIS-R score at baseline, age (< or ≥ 18) depression severity (mild, m
depression (yes, no).
*High scores reflect better quality of life.
** Higher scores reflect greater cognitive awareness.Again, after adjustment for baseline CIS-R score and the 4
key design variables the intervention group had a mean
CIS-R score that was 12.6 points lower than those in the
usual care group (Table 4).
Other outcomes at 15 and 33 weeks – proposed
secondary
The results for the other secondary outcomes at 15 -
weeks and 33 weeks are given in Table 4. Those women
who were randomised to the intervention were less
depressed (on both the PHQ-9 and EPDS) compared to
those who were randomised to continue with usual care.
Mental health related quality of life assessed using the
SF-12 mental health component score showed those in
the intervention group reported better mental health at
15 and 33 weeks. Physical functioning (SF-12 physical
component) improved over time but there was only
weak evidence of a difference between the two groups.
The EQ-5D was also administered at both follow-upween the intervention and usual care groups at 15 and
33 weeks post-randomisation (in the postnatal period)
ce in
CI)
Intervention UC Adjusted difference in
means (1) (95% CI)
p valuen Mean
(sd)
n Mean
(sd)
.9) p= 16 9.8 (8.8) 11 22.4 (11.9) −12.6 (−21.1 to −4.2) p=
0.005
p= 0.01 16 7.1 (4.8) 11 13.7 (6.2) −6.8 (−11.3 to −2.2) p= 0.005
= 0.01 16 6.2 (4.3) 11 10.7 (5.8) −4.7 (−8.8 to −0.6) p= 0.03
= 0.09 15 39.8 (6.9) 11 44.9 (12.1) −7.5 (−15.3 to 0.3) p= 0.06
0.001 15 49.2 (4.6) 11 42.8 (11.0) 7.5 (0.9 to 14.0) p= 0.03
= 0.06 15 42 (5.8) 10 39.7 (9.7) 5.0 (−0.5 to 10.4) p= 0.07
p= 0.26 15 0.90 (0.13) 11 0.78 (0.11) 0.13 (0.03 to 0.22) p= 0.01
= 0.01 - - - - -
oderate or severe), current symptom duration (< or ≥ 3 months) and history of
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http://www.biomedcentral.com/1471-244X/13/33time points. Both groups had similar mean scores at 15 -
weeks but those in the intervention group had a higher
mean score at 33 weeks than those receiving only usual
care indicating some evidence of better health. Mean
scores on the meta-cognitive awareness questionnaire
improved over time but did not differ between the
groups. The prenatal attachment inventory used at 15 -
weeks reported women in the intervention group had a
higher mean score (60.4) compared to the women re-
ceiving only usual care (47.2) indicating some evidence
of an increased attachment to their baby, although these
differences could have been apparent at baseline.
Health economic data
Of the 29 women who completed their 15 weeks follow-
up assessment, 24 completed a Resource Use Question-
naire (RUQ). At 33 weeks, of the 27 women who were
followed up, 25 completed the RUQ, only 21 women
completed RUQs at both follow-up time points. Table 5
shows the mean level of resource use, using all available
data for the 33 women.
In order to compare the resource-use measurement
collection methods, analyses were conducted only on
those women who had complete information from the
comparative sources. For midwife appointments, RUQ
and maternity note collection methods were comparable
(Table 6). GP record extractions differed significantly
from both RUQ and maternity note extractions and in
terms of GP visits, GP records recorded a higher median
number of GP visits than the RUQ.
Information from medical records and maternity notes
were recorded. Medical record searches were conducted
on 33 women, as 2 women withdrew from the study and
1 woman had a miscarriage. Of those 33 women, infor-
mation from 29 maternity notes were collected, with the
team unable to access 4 women’s maternity notes due to
moving out of the area. The average number of antenatal
appointments was 13 (range 7–25, SD= 4.1), with a
mean of 9 midwife appointments (range= 2–21, SD=
3.6) and a mean of 3 scans (range= 1–6, SD=1.2).
Antidepressant use
Any interventions the women received as part of usual care
(in both groups) were recorded. Medical records showed
that over a third (39.4%; 13/33) of the women had been
prescribed antidepressants in the year before randomisa-
tion. The majority of those women (69.2%; 9/13) were tak-
ing an antidepressant during their pregnancy (2 women inTable 5 Resource-use data using all available data for the 33
Maternity note
Mean (st dev) number of GP visits per month N/A
Mean (st dev) number of midwife visits per month 0.96 (0.41) n=2the intervention, 7 usual care), however 3 women stopped
taking them after giving birth (all in usual care). Of the 4
women who were not prescribed antidepressants during
pregnancy, 3 women were prescribed them after giving
birth (1 in the intervention, 2 in usual care).
Referral information for the treatment of depression from
medical notes
According to medical records, very few women in the
trial had any referrals in relation to a diagnosis of de-
pression in the year prior to randomisation. The major-
ity (72.7%; 24/33) had nothing recorded in their medical
notes regarding any referrals, 21.2% (7/33) had a referral
made for them and only 6.1% (2/33) women had
‘discussed’ a referral with their doctor. During the study
period, fewer women who received the intervention
(14.3%; 1/7) had a referral compared to those in usual
care (85.7%; 6/7). All those referrals were to a psycho-
logical treatment service, 5 women were referred to or
assessed by a specialist perinatal psychiatry service and 2
were referred to another service, although there was no
information available on whether treatment was started
or completed (See Table 7).
Discussion
To our knowledge, this is the first trial of CBT looking
at treating depression by the end of pregnancy, with the
aim of assessing the feasibility of delivering a CBT inter-
vention modified for antenatal depression during the
antenatal period. The results of this pilot study suggest
that it is feasible to complete CBT with some adaptation
for context, before the end of pregnancy. Although the
sample of the study was small, the results suggest that
CBT could be effective in reducing the symptoms of
antenatal depression by the end of pregnancy.
Feasibility of recruitment
We found it was possible to recruit women through mid-
wife booking appointments, however, midwives only re-
ferred 65.6% of those eligible for assessment. There was a
significant loss from those attending booking appointments
and those randomised mainly due to busy midwives not
inviting women to take part in the study. Booking
appointments involve the collection of a great deal of infor-
mation and any future trial in this area would need to iden-
tify other additional ways of recruiting women. Posters in
waiting rooms or mail outs from surgeries could be other
possibilities. Midwives subsequently reported that theywomen
s GP records Self report questionnaire (RUQ)
0.67 (0.47) n=33 0.45 (0.35) n=20
9 0.46 (0.40) n=33 0.95 (0.60) n=13
Table 6 Comparisons of resource-use measurement collection methods (Wilcoxon signed-ranks tests)
Per month n Maternity notes GP records Self-report RUQ p-value
Median number GP visits per month (GP records and self report RUQ) 20 N/A 0.53 0.36 0.1
Median number midwife visits per month (GP records and RUQ) 13 N/A 0.13 0.92 0.009
Median number midwife visits per month (maternity notes and RUQ) 11 0.92 N/A 1.03 0.5
Median number midwife visits per month (GP records and maternity notes) 29 0.92 0.53 N/A <0.001
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seminars and education to encourage them to refer to men-
tal health research studies is important, as extending the
reach to many of those women who were not asked to take
part is essential.Delivery of therapy
An important aim of this study was to assess whether
we could deliver CBT in a sufficiently timely fashion to
show benefit before the end of pregnancy. It was there-
fore important that women were identified early in preg-
nancy and assessed rapidly. The time between booking
appointments and randomisation was on average 3 -
weeks, although we believe this could be shortened by
focusing research team resources at this point.
Based on clinical improvements in weekly self-reported
depression scores collected as part of CBT sessions, the
therapists judged that 8 to 9 sessions were often sufficient,
however as 12 sessions were offered initially this set up an
expectation that made it difficult to end earlier (for both
client and therapist). We propose that for any future study
that a more reasonable approach would be to ‘treat until
well’ with a limit of 12 sessions, as residual symptoms may
be linked to negative child outcomes. Also it is clearly im-
portant to avoid unnecessary sessions in order to maxi-
mise potential for cost effectiveness.Table 7 Referral information for the treatment of depression
Total sam
Year prior to randomisation n= 33
Nothing recorded 24
Referral made to: 7
Psychological treatment service
Drug and Alcohol service
Crisis team A&E psychiatric team
Discussed low mood 2
During the study period n= 7
Assessed on a specialist perinatal unit 3
Referred to a specialist perinatal unit 2
Referred to a psychological treatment service 1
Received phone counselling sessions 1One aspect of this intervention which is different from
standard CBT is that it was offered to women in their own
homes. All but one woman took up this option which was
designed to increase the accessibility of the therapy in
order to maximise attendance at sessions. DNA rates for
cancelled sessions were low (5.6%) and this is comparable
to previous studies [47,48]. Therapy at home is particularly
relevant for women who are continuing to work and those
who had problems arranging childcare. Previous studies
have found that women have reported that some of the
major barriers to treatment are the practical ones such as
lack of time, childcare issues, and being seen in a hospital
setting [49,50]. However, the therapists reported that ther-
apy seemed less formal when conducted in the home and
that the setting influenced the relationship between ther-
apist and participant in subtle ways which might influence
the effectiveness of the intervention through changes in
nonspecific factors (i.e. therapist as authority) of any of
the intervention [51]. Therapists offered to conduct
sessions even when young children were present if child-
care could not be set up, however women generally did
not want to do this as they felt their child would interfere
with the CBT. These issues could have implications for
the cost-effectiveness, as providing CBT at home reduces
the capacity of the therapist. However, there is growing
evidence from other studies that telephone based and
internet CBT is more accessible, as acceptable andfrom medical notes
ple Intervention Usual care
n=18 n=15
14 10
2 2
1 -
- 1
- 1
1 1
n= 1 n= 6
- 3
1 1
- 1
- 1
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of delivery needs to be considered to ensure generalisabilty
without compromising effectiveness.
Other methodological issues
The early identification and recruitment of women (be-
tween 8 and 18 weeks) with depression during pregnancy
means there will be a number of drop outs due to miscar-
riage before assessment, and these women are also at risk
of having depression. Also those women with an onset of
depression later in pregnancy will be missed. The only
way to address this would be to extend the intervention to
those at high risk of developing depression during preg-
nancy but the cost effectiveness of such an approach in-
cluding an element of depression, would need to be
considered.
Although this is a pilot trial and the sample was small,
one potential source of bias that this pilot has highlighted
is the higher dropout rate in the usual care only group.
Other depression trials have reported being able to avoid
differential attrition by having sufficient funds to increase
contact between appointments [55]. Keeping in touch by
letter or telephone between assessments might help to
minimise this problem in a large trial, although such con-
tact should be minimal (and to both groups) to avoid con-
tamination from any potential therapeutic benefit that
might arise.
Use of resources
The numbers of women returning information on re-
source use was not sufficiently large to draw any
confident conclusions. However, collection of data on re-
source use indicates that for midwife contacts self-
reported resource use appears to be as reliable as mater-
nity notes, whereas it appears that many maternity
appointments are not recorded in GP records, which
should be discounted as a reliable means of obtaining
maternity information. In terms of GP visits, self-report
appeared to under estimate contacts with GP compared
with GP records; this confirms earlier work, albeit in a
different patient group, that found elderly patients
underestimate resource use even within a short time
frame [56]. In a future trial if it is too expensive to col-
lect information from GP records, using resource-use
logs to aid memory could be considered.
Conclusion
This pilot RCT indicates that it would be feasible to con-
duct a full scale trial to assess the effectiveness of CBT
given in addition to usual care, compare to usual care
alone, for the treatment for antenatal depression. Strat-
egies are needed to improve referral of potentially eli-
gible women by midwives to such a trial. The promising
results from this pilot trial suggest that there could bepotential benefits of such an intervention to the mother
and therefore to wider family and the developing child.
A sufficiently large trial to provide evidence of the effect-
iveness and cost effectiveness of such an intervention is
needed, as this cannot be assumed by simply extrapolat-
ing from evidence outside the antenatal period.
Abbreviations
RCT: Randomised Controlled Trial; CBT: Cognitive behavioural therapy;
GP: General Practitioner; NICE: National Institute for Clinical Excellence; CIS-
R: Clinical Interview Schedule – Revised version; EPDS: Edinburgh Postnatal
Depression Scale; PHQ-9: The Patient Health Questionnaire; RUQ: Resource-
use questionnaires.
Competing interests
The Authors declare that they have no competing interests.
Authors’ contributions
JE, HO, NW, PR, DS, KT were responsible for the conception and design, and
securing funding for the trial. JE as principal investigator had overall
management responsibility of the study. AB and HB, as trial coordinators,
were responsible for the day to day running of the trial and data collection.
KB was involved in the data collection. HO provided clinical supervision
throughout the trial. AB led the analysis and interpretation of the data with
supervision from JE and NW, drafted the article and revised the article. JT
jointly designed the RUQ and analysed the health economic data under the
supervision of SN. SN jointly designed the RUQ. All authors revised, read and
approved the final version of the paper for publication.
Acknowledgements
We would like to say many thanks to all the women who participated in our
study and all the midwives who helped with referring women. Thanks to
Cathy Jones and Louise Urquhart, the therapist, for all their hard worked
throughout the study. Thanks to Davina Chauhan from the MHRN for her
support. This work was funded by the National Institute for Health Research,
RfPB grant number, PB-PG-1207-15063.
Author details
1Centre for Mental Health, Addiction and Suicide Research, School of Social
and Community Medicine, University of Bristol, Oakfield House, Oakfield
Grove, Clifton, Bristol BS8 2BN, UK. 2Department of Mood Disorder, University
of Exeter, Exeter EX4 4QG, UK. 3Academic Unit of Child and Adolescent
Psychiatry, Imperial College, London W2 1PG, UK. 4Centre for Academic Unit
of Primary Care, School of Social and Community Medicine, University of
Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK. 5School of Social
and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley
Road, Bristol BS8 2PS, UK.
Received: 5 September 2012 Accepted: 14 January 2013
Published: 22 January 2013
References
1. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T:
Perinatal depression: a systematic review of prevalence and incidence.
Obstet Gynecol 2005, 106(5 Pt 1):1071–1083.
2. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G: Perinatal risks of
untreated depression during pregnancy. Can J Psychiat 2004,
49(11):726–735.
3. Lobel M, Dunkelschetter C, Scrimshaw SCM: Prenatal maternal stress and
prematurity - a prospective-study of socioeconomically disadvantaged
women. Health Psychol 1992, 11(1):32–40.
4. Lou HC, Hansen D, Nordentoft M, Pryds O, Jensen F, Nim J, Hemmingsen R:
Prenatal stressors of human life affect fetal brain-development. Dev Med Child
Neurol 1994, 36(9):826–832.
5. Wadhwa PD, Sandman CA, Porto M, Dunkelschetter C, Garite TJ: The
association between prenatal stress and infant birth-weight and
gestational-Age at birth - a prospective investigation. Am J Obstet
Gynecol 1993, 169(4):858–865.
Burns et al. BMC Psychiatry 2013, 13:33 Page 11 of 12
http://www.biomedcentral.com/1471-244X/13/336. Heron J, O’Connor TG, Evans J, Golding J, Glover V: The course of anxiety and
depression through pregnancy and the postpartum in a community sample.
J Affect Disord 2004, 80(1):65–73.
7. O’Connor TG, Heron J, Golding J, Glover V, Team AS: Maternal antenatal
anxiety and behavioural/emotional problems in children: a test of a
programming hypothesis. J Child Psychol Psyc 2003, 44(7):1025–1036.
8. Teixeira JMA, Fisk NM, Glover V: Association between maternal anxiety in
pregnancy and increased uterine artery resistance index: cohort based
study. Brit Med J 1999, 318(7177):153–157.
9. Zuckerman B, Amaro H, Bauchner H, Cabral H: Depressive symptoms
during pregnancy: relationship to poor health behaviors. Am J Obstet
Gynecol 1989, 160(5 Pt 1):1107–1111.
10. Shah N, Howard L: Screening for smoking and substance misuse in pregnant
women with mental illness. Psychiatr Bull 2006, 30(8):294–297.
11. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O: Depression and
anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 2000,
95(4):487–490.
12. Schmeelk KH, Granger DA, Susman EJ, Chrousos GP: Maternal depression
and risk for postpartum complications: Role of prenatal corticotropin-
releasing hormone and interleukin-1 receptor antagonist. Behav Med
1999, 25(2):88–94.
13. Hoffman S, Hatch MC: Depressive symptomatology during pregnancy:
Evidence for an association with decreased fetal growth in pregnancies
of lower social class women. Health Psychol 2000, 19(6):535–543.
14. Hedegaard M, Henriksen TB, Sabroe S, Secher NJ: Psychological distress in
pregnancy and preterm delivery. Brit Med J 1993, 307(6898):234–239.
15. Rini CK, Dunkel-Schetter C, Wadhwa PD, Sandman CA: Psychological
adaptation and birth outcomes: The role of personal resources, stress,
and sociocultural context in pregnancy. Health Psychol 1999, 18(4):333–345.
16. Lundy BL, Jones NA, Field T, Nearing G, Davalos M, Pietro PA, Schanberg S,
Kuhn C: Prenatal depression effects on neonates. Infant Behav Dev 1999,
22(1):119–129.
17. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ: A meta-
analysis of depression during pregnancy and the risk of preterm birth,
low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry
2010, 67(10):1012–1024.
18. NICE: Antenatal and postnatal mental health: Clinical management and
service guidance. G45, National Institue for Health and Clinical Excellence.
London: DoH; 2007.
19. Dennis CL, Allen K: Interventions (other than pharmacological,
psychosocial or psychological) for treating antenatal depression.
Cochrane Database Syst Rev 2008, (4):CD006795.
20. Sockol LE, Epperson CN, Barber JP: A meta-analysis of treatments for
perinatal depression. Clin Psychol Rev 2011, 31(5):839–849.
21. Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A: Preventing
the onset of depressive disorders: A meta-analytic review of
psychological interventions. Am J Psychiat 2008, 165(10):1272–1280.
22. Spinelli MG: Interpersonal psychotherapy for depressed antepartum
women: a pilot study. Am J Psychiatry 1997, 154(7):1028–1030.
23. Dennis CL: Psychosocial and psychological interventions for prevention of
postnatal depression: systematic review. Brit Med J 2005, 331(7507):15–18.
24. Cho HJ, Kwon JH, Lee JJ: Antenatal cognitive-behavioral therapy for
prevention of postpartum depression: A pilot study. Yonsei Med J 2008,
49(4):553–562.
25. Freeman MP: New data inform the risk/benefit analysis in antenatal
depression. J Clin Psychiat 2007, 68(8):1277–1278.
26. Freeman MP: Antenatal depression: Navigating the treatment dilemmas.
Am J Psychiat 2007, 164(8):1162–1165.
27. Thormahlen GM: Paroxetine use during pregnancy: Is it safe? Ann
Pharmacother 2006, 40(10):1834–1837.
28. Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB,
Norgaard M, Stephansson O, Valdimarsdottir U, et al: Selective serotonin
reuptake inhibitors during pregnancy and risk of persistent pulmonary
hypertension in the newborn: population based cohort study from the
five Nordic countries. Brit Med J 2012, 344.
29. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J: Effects of
antenatal depression and antidepressant treatment on gestational age
at birth and risk of preterm birth. Am J Psychiat 2007, 164(8):1206–1213.
30. Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM: Risk factors
for depressive symptoms during pregnancy: a systematic review (vol
202, pg 5, 2010). Am J Obstet Gynecol 2011, 205(3):236–236.31. Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J: Effect of the
addition of a “help” question to two screening questions on specificity
for diagnosis of depression in general practice: diagnostic validity study.
BMJ 2005, 331(7521):884.
32. Lewis G, Pelosi AJ, Araya R, Dunn G: Measuring psychiatric-disorder in the
community - a standardized assessment for Use by Lay interviewers.
Psychol Med 1992, 22(2):465–486.
33. O’Mahen H, Fedock G, Henshaw E, Himle JA, Forman J, Flynn HA:
Modifying CBT for perinatal depression: what Do women want? a
qualitative study. Cogn Behav Pract 2012, 19(2):359–371.
34. Blackburn IM, James IA, Milne DL, Baker C, Standart S, Garland A, Reichelt FK:
The revised cognitive therapy scale (Cts-R): psychometric properties.
Behav Cogn Psychother 2001, 29(4):431–446.
35. Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and
recurrence in unipolar depression: a comparative meta-analysis of
cognitive-behavioral therapy’s effects. J Consult Clin Psychol 2007, 75(3):
475–488.
36. Anderson EM, Lambert MJ: A survival analysis of clinically significant
change in outpatient psychotherapy. J Clin Psychol 2001, 57(7):875–888.
37. Hansen NB, Lambert MJ, Forman EM: The psychotherapy dose–response
effect and its implications for treatment delivery services. Clin Psychol-Sci
Pr 2002, 9(3):329–343.
38. Jane-Llopis E, Hosman C, Jenkins R, Anderson P: Predictors of efficacy in
depression prevention programmes. Meta-analysis. The British journal of
psychiatry. J Ment Sci 2003, 183:384–397.
39. Brugha TS, Morgan Z, Bebbington P, Jenkins R, Lewis G, Farrell M, Meltzer H:
Social support networks and type of neurotic symptom among adults in
British households. Psychol Med 2003, 33(2):307–318.
40. Brugha TS, Meltzer H, Jenkins R, Bebbington PE, Taub NA: Comparison of
the CIS-R and CIDI lay diagnostic interviews for anxiety and depressive
disorders. Psychol Med 2005, 35(7):1089–1091.
41. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief
depression severity measure. J Gen Intern Med 2001, 16(9):606–613.
42. Cox JL, Holden JM, Sagovsky R: Detection of postnatal depression.
Development of the 10-item Edinburgh Postnatal Depression Scale. The
British journal of psychiatry. J Ment Sci 1987, 150:782–786.
43. Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey -
Construction of scales and preliminary tests of reliability and validity.
Med Care 1996, 34(3):220–233.
44. William A: EuroQol–a new facility for the measurement of health-related
quality of life. The EuroQol Group. Health Policy 1990, 16(3):199–208.
45. Muller ME: Development of the prenatal attachment inventory. West J
Nurs Res 1993, 15(2):199–211. discussion 211–195.
46. Teasdale JD, Scott J, Moore RG, Hayhurst H, Pope M, Paykel ES: How does
cognitive therapy prevent relapse in residual depression? Evidence from
a controlled trial. J Consult Clin Psychol 2001, 69(3):347–357.
47. O’Mahen HH, Fedock G, Henshaw E, Flynn HA: A pilot randomized
controlled trial of cognitive behavioural therapy adapted for women
with low incomes in prenatal care settings. Depress Anxiety, . submitted.
48. Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T:
Treating depression in predominantly low-income young minority women -
A randomized controlled trial. Jama J Am Med Assoc 2003, 290(1):57–65.
49. O’Mahen HA, Flynn HA: Preferences and perceived barriers to treatment
for depression during the perinatal period. J Womens Health 2008,
17(8):1301–1309.
50. Goodman JH: Women’s Attitudes, preferences, and perceived barriers to
treatment for perinatal depression. Birth-Iss Perinat C 2009, 36(1):60–69.
51. Frank JF, Frank JD: Persuasion and healing persuasion: a comparative study of
psychotherapy. Baltimore, London: Johns Hopkins University Press; 1994.
52. Gask L, Bower P, Lamb J, Burroughs H, Chew-Graham C, Edwards S, Hibbert
D, Kovand IM, Lovell K, Rogers A, et al: Improving access to psychosocial
interventions for common mental health problems in the United
Kingdom: narrative review and development of a conceptual model for
complex interventions. BMC Heal Serv Res 2012, 12(1):249.
53. Lovell K, Bee P: Optimising treatment resources for OCD: a review of the
evidence base for technology-enhanced delivery. J Ment Health 2011,
20(6):525–542.
54. Lovell K, Cox D, Haddock G, Jones C, Raines D, Garvey R, Roberts C, Hadley
S: Telephone administered cognitive behaviour therapy for treatment of
obsessive compulsive disorder: randomised controlled non-inferiority
trial. BMJ 2006, 333(7574):883.
Burns et al. BMC Psychiatry 2013, 13:33 Page 12 of 12
http://www.biomedcentral.com/1471-244X/13/3355. Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Haase AM, Taylor AH, Fox KR,
Costelloe C, Searle A, Baxter H, et al: Facilitated physical activity as a treatment
for depressed adults: randomised controlled trial. Brit Med J 2012, 344:e2758.
56. Richards SH, Coast J, Peters TJ: Patient-reported use of health service
resources compared with information from health providers. Health Soc
Care Community 2003, 11(6):510–518.
doi:10.1186/1471-244X-13-33
Cite this article as: Burns et al.: A pilot randomised controlled trial of
cognitive behavioural therapy for antenatal depression. BMC Psychiatry
2013 13:33.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
